Douglas G. Watson
Directeur Général chez Pittencrieff Glen Associates
Profil
Douglas G.
Watson founded Pittencrieff Glen Associates in 1999, where he is working as Chief Executive Officer from 2011.
Mr. Watson also currently works at ImmunSYS, Inc., as Director, Syncromune, Inc., as Director, and The Chartered Institute of Management Accountants, as Member from 2009.
Mr. Watson also formerly worked at Ciba-Geigy Corp., as President & Chief Executive Officer in 1996, Novartis Corp., as President & Chief Executive Officer from 1997 to 1999, Valigen NV, as President & Chief Executive Officer from 2000 to 2001, Dendreon Corp., as Chairman from 2014 to 2015, OraSure Technologies, Inc., as Chairman from 2002 to 2016, Genta, Inc., as Vice Chairman from 2002 to 2011, Javelin Pharmaceuticals, Inc., as Chairman from 2004 to 2010, Freedom House Foundation, as Chairman, Engelhard Corp., as Director from 1991 to 2006, Summit Bank Corp.
(Georgia), as Director, Delcath Systems, Inc., as Director from 2010 to 2011, Informedix Holdings, Inc., as Director, Intrac, Inc., as Director, Wright Medical Group, Inc., as Independent Director from 2014 to 2015, Innovative Drug Delivery Systems, Inc., as Director, BioMimetic Therapeutics, Inc., as Director in 1999, Accelerated Pharma, Inc., as Independent Director, BASF Catalysts LLC, as Director, Pharmaceutical Research & Manufacturers of America, as Director, American Liver Foundation, as Director, Informedix, Inc., as Director from 2002 to 2006, BZL Biologics, Inc., as Director, BioElectronics, Inc., as Director from 2002 to 2006, Bionor Immuno AS, as Director, and Ciba Pharmaceuticals, as President from 1986 to 1996.
Mr. Watson received his graduate degree from Churchill College.
Postes actifs de Douglas G. Watson
| Sociétés | Poste | Début |
|---|---|---|
| Pittencrieff Glen Associates | Directeur Général | 01/06/1999 |
The Chartered Institute of Management Accountants
 The Chartered Institute of Management Accountants Other Consumer ServicesConsumer Services The Chartered Institute of Management Accountants, also known as aicpa® & cima®, is a global organization with 689,000 members, students, and professionals. The non-profit company is based in London, UK, and has a global presence of subsidiaries in several regions. The British company advocates for the accounting and finance profession, as well as the public interest and business sustainability. Andrew Harding has been the CEO of the company since 2009. | Corporate Officer/Principal | - |
ImmunSYS, Inc.
 ImmunSYS, Inc. Pharmaceuticals: MajorHealth Technology ImmunSYS, Inc. is a clinical stage biopharmaceutical company focused on the development of cancer immunotherapy products. The company was founded by Eamonn P. Hobbs and Charles J. Link Jr. in March 2018 and is headquartered in Fort Lauderdale, FL. | Directeur/Membre du Conseil | - |
Syncromune, Inc.
 Syncromune, Inc. Pharmaceuticals: MajorHealth Technology Syncromune, Inc. is a clinical-stage biopharmaceutical company that is dedicated to developing an in situ platform technology optimized for metastatic solid tumor cancers. The company is based in Fort Lauderdale, FL. The company is currently developing Sync-T™, a novel combination drug/device treatment platform that aims to achieve high response rates with potentially curative efficacy. The therapy is designed to synchronize in situ neoantigen T cell education and immunostimulation via intratumoral/locoregional infusion, with the goal of enabling the immune system to recognize and attack cancer throughout the body. The first two candidates, SV-101 and SV-102, are currently in investigator-initiated phase 1 trials. Link. The company was founded in 2020 by Charles J. Eamonn P. Hobbs has been the CEO of the company since 2020. | Directeur/Membre du Conseil | - |
Anciens postes connus de Douglas G. Watson
| Sociétés | Poste | Fin |
|---|---|---|
| ORASURE TECHNOLOGIES, INC. | Président | 13/11/2016 |
| WRIGHT MEDICAL GROUP INC | Directeur/Membre du Conseil | 01/10/2015 |
| DENDREON CORPORATION | Président | 10/06/2015 |
BioMimetic Therapeutics, Inc.
 BioMimetic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology BioMimetic Therapeutics, Inc. developed and sells protein therapeutics for tissue and organ regeneration. The company was founded by Samuel E. Lynch and David M. Renzi on April 14, 1999 and was headquartered in Franklin, TN. | Directeur/Membre du Conseil | - |
Genta, Inc.
 Genta, Inc. Pharmaceuticals: MajorHealth Technology Genta, Inc. is in the process of bankruptcy. The company formerly engages in pharmaceutical research and development. Genta was founded on February 4, 1988 and is headquartered in Berkeley Heights, NJ. | Directeur/Membre du Conseil | 20/01/2011 |
Formation de Douglas G. Watson
| Churchill College | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ORASURE TECHNOLOGIES, INC. | Health Technology |
| DELCATH SYSTEMS, INC. | Health Technology |
| Entreprise privées | 27 |
|---|---|
| Ciba-Geigy Corp. | Health Technology |
Engelhard Corp.
 Engelhard Corp. Chemicals: Major DiversifiedProcess Industries Engelhard Corp. is a surface and materials science company that provides technologies for environmental, process, appearance and performance applications. It enables customers to improve the productivity of their processes with a wide range of technologies available, it serves a broad range of chemical market segments, including petrochemicals, oleochemicals and fine chemicals. | Process Industries |
| Summit Bank Corp. (Georgia) | Finance |
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
Informedix Holdings, Inc.
 Informedix Holdings, Inc. Medical SpecialtiesHealth Technology InforMedix Holdings, Inc. develops integrated portable patient monitoring units, hardware, software and networked communications system to enable consumers, pharmacists, health plans, disease management organizations, pharmaceutical and biomedical companies, medical researchers and physicians to monitor and manage patients' medication adherence and clinical response. The company was founded on January 19, 2000 is headquartered in Rockville, MD. | Health Technology |
Intrac, Inc.
 Intrac, Inc. Financial ConglomeratesFinance The Group's principal activity is to develop new drug and improve formulations of existing drug that target current unmet and underserved medical need primarily in the pain management market. It develops simple and user-friendly products, including new modes and routes of delivery for drugs optimized for relieving moderate-to-severe pain. The Group is in the development stage. | Finance |
Wright Medical Group, Inc.
 Wright Medical Group, Inc. Medical SpecialtiesHealth Technology Wright Medical Group, Inc. designs, manufactures and distributes biologic products. It provides surgical solutions for the foot and ankle markets. The company was founded by Frank O. Wright and is headquartered in Memphis, TN. | Health Technology |
Innovative Drug Delivery Systems, Inc.
 Innovative Drug Delivery Systems, Inc. Pharmaceuticals: MajorHealth Technology IDDS is a specialty pharmaceutical company that applies innovative proprietary technologies to develop new drugs and improved formulations of existing drugs that target current unmet and underserved medical need in the pain management market. IDDS’s product candidates address the market segment for prescription medications focused on treating acute and episodic moderate-to-severe pain associated with breakthrough cancer pain, post operative pain, orthopedic injury, procedural pain, burn pain and trauma. The product candidates offer enhanced pain relief, fewer adverse side effects and faster relief of pain compared to other currently available treatments. | Health Technology |
Genta, Inc.
Genta, Inc. Pharmaceuticals: MajorHealth Technology Genta, Inc. is in the process of bankruptcy. The company formerly engages in pharmaceutical research and development. Genta was founded on February 4, 1988 and is headquartered in Berkeley Heights, NJ. | Health Technology |
BioMimetic Therapeutics, Inc.
BioMimetic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology BioMimetic Therapeutics, Inc. developed and sells protein therapeutics for tissue and organ regeneration. The company was founded by Samuel E. Lynch and David M. Renzi on April 14, 1999 and was headquartered in Franklin, TN. | Health Technology |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
The Chartered Institute of Management Accountants
The Chartered Institute of Management Accountants Other Consumer ServicesConsumer Services The Chartered Institute of Management Accountants, also known as aicpa® & cima®, is a global organization with 689,000 members, students, and professionals. The non-profit company is based in London, UK, and has a global presence of subsidiaries in several regions. The British company advocates for the accounting and finance profession, as well as the public interest and business sustainability. Andrew Harding has been the CEO of the company since 2009. | Consumer Services |
Accelerated Pharma, Inc.
 Accelerated Pharma, Inc. Medical SpecialtiesHealth Technology Accelerated Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in development of pre-existing pharmaceutical products for the treatment of various cancer indications. It offers a platinum-based cancer therapy that has the potential for use in different formulations, as a single agent or in combination with other anti-cancer agents, to treat multiple cancer indications under the Picoplatin brand. The company was founded by Michael Fonstein, Ekaterina E. Nikolaevskaya and Dmitry Prudnikov in May 2014 and is headquartered in Westport, CT. | Health Technology |
Valigen NV
 Valigen NV Miscellaneous Commercial ServicesCommercial Services Valigen NV offers genotyping and functional genomics. The company is headquartered in Newtown, PA. | Commercial Services |
Javelin Pharmaceuticals, Inc.
 Javelin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Javelin Pharmaceuticals, Inc. develops pharmaceutical drugs. It is a specialty pharmaceutical company that applies innovative proprietary technologies to develop new drugs and improved formulations of existing drugs that target current unmet and underserved medical market. The company's product candidates address the acute moderate-to-severe pain medication market segment. It has three late stage product candidates in development: Dyloject (diclofenac sodium, injectable), Rylomine (intranasal morphine) and PMI-150 (intranasal ketamine). The company was founded on February 23, 1998 and is headquartered in Cambridge, MA. | Health Technology |
BASF Catalysts LLC
 BASF Catalysts LLC Integrated OilEnergy Minerals BASF Catalysts LLC supplies environmental and process catalysts. Its products include emission-control systems for automobiles and segments produce pigments and performance additives, chemical catalysts and sorbents. The company was founded in 1908 and is headquartered in Iselin, NJ. | Energy Minerals |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Health Technology |
| Pittencrieff Glen Associates | |
American Liver Foundation
 American Liver Foundation Miscellaneous Commercial ServicesCommercial Services American Liver Foundation engages in facilitating, advocating and promoting education, support, and research for the prevention, treatment, and cure of liver disease. It educates patients, policymakers and the public and provides grants to early-career researchers to help find a cure for all liver diseases. The company was founded in 1976 and is headquartered in New York, NY. | Commercial Services |
| Freedom House Foundation | |
Informedix, Inc.
 Informedix, Inc. Information Technology ServicesTechnology Services Part of Informedix Holdings, Inc., Informedix, Inc. develops portable and patient-based telehealth technology. The company is based in Rockville, MD. | Technology Services |
| Ciba Pharmaceuticals | |
| BZL Biologics, Inc. | |
| BioElectronics, Inc. | |
Bionor Immuno AS
 Bionor Immuno AS Miscellaneous Commercial ServicesCommercial Services Bionor Immuno AS engages in the research and development of biomedicine. It also owns and manages shares and other securities. The company was founded on July 14, 2000 and is headquartered in Oslo, Norway. | Commercial Services |
ImmunSYS, Inc.
ImmunSYS, Inc. Pharmaceuticals: MajorHealth Technology ImmunSYS, Inc. is a clinical stage biopharmaceutical company focused on the development of cancer immunotherapy products. The company was founded by Eamonn P. Hobbs and Charles J. Link Jr. in March 2018 and is headquartered in Fort Lauderdale, FL. | Health Technology |
Syncromune, Inc.
Syncromune, Inc. Pharmaceuticals: MajorHealth Technology Syncromune, Inc. is a clinical-stage biopharmaceutical company that is dedicated to developing an in situ platform technology optimized for metastatic solid tumor cancers. The company is based in Fort Lauderdale, FL. The company is currently developing Sync-T™, a novel combination drug/device treatment platform that aims to achieve high response rates with potentially curative efficacy. The therapy is designed to synchronize in situ neoantigen T cell education and immunostimulation via intratumoral/locoregional infusion, with the goal of enabling the immune system to recognize and attack cancer throughout the body. The first two candidates, SV-101 and SV-102, are currently in investigator-initiated phase 1 trials. Link. The company was founded in 2020 by Charles J. Eamonn P. Hobbs has been the CEO of the company since 2020. | Health Technology |
